Form D — Matinas BioPharma Holdings, Inc.
0001493152-25-007569 · filed Feb 19, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,300,000
- Reported amount sold
- $1,650,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Matinas BioPharma Holdings, Inc.
- CIK
- 1582554
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1545 ROUTE 206 SOUTH
BEDMINSTER, New Jersey 07921 - Phone
- 908-443-1860
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jerome Jabbour · Executive OfficerBEDMINSTER, New Jersey Find on LinkedIn ↗
-
Keith Kucinski · Executive OfficerBEDMINSTER, New Jersey Find on LinkedIn ↗
-
Eric Ende · DirectorBEDMINSTER, New Jersey Find on LinkedIn ↗
-
Robin Smith · DirectorBEDMINSTER, New Jersey Find on LinkedIn ↗
-
Evelyn D'An · DirectorBEDMINSTER, New Jersey Find on LinkedIn ↗
-
Natasha Giordano · DirectorBEDMINSTER, New Jersey Find on LinkedIn ↗
-
Matthew Wikler · DirectorBEDMINSTER, New Jersey Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗